Vitro medis, UAB - financials and debts

Company age: 7 y. 5 mo.

Update

Vitro medis - Company finances

EUR
2019
From: 2019-04-05
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 34,800 461,024 434,466 529,427 63,749 66,900 358,755
Profit before tax 21,593 307,373 157,462 -33,762 32,438 -34,425 237
Net profit 20,725 264,175 149,653 -33,762 32,438 -34,425 237
Equity 23,225 266,675 373,131 382,567 447,724 431,409 424,946
Liabilities 3,092 455,199 454,843 15,566 34,110 12,417 53,008
Non-current assets 2,110 196,748 98,586 22,125 17,571 4 29,331
Current assets 24,207 525,126 729,388 375,694 463,899 443,389 447,122
Total assets 26,317 721,874 827,974 397,819 481,470 443,393 476,453
Taxes paid
STI taxes - - - - 5,300 3,338 -
Social insurance contributions - - - - - 3,277 8,222
Financial indicators
Revenue change y/y - +1224.8% -5.8% +21.9% -88.0% +4.9% +436.3%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 78.8% 36.6% 18.1% -8.5% 6.7% -7.8% 0.0%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 89.2% 99.1% 40.1% -8.8% 7.2% -8.0% 0.1%
Profit margin Net profit margin. Shows the overall profitability of the company. 59.6% 57.3% 34.4% -6.4% 50.9% -51.5% 0.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 62.0% 66.7% 36.2% -6.4% 50.9% -51.5% 0.1%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.1 1.7 1.2 0.0 0.1 0.0 0.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 34,800 276,609 54,308 76,543 31,875 19,114 89,689

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Vitro medis - Social security debts

From To Debt, €
2025-06-17 2025-06-24 0.61
2025-06-08 2025-06-09 0.61
2025-05-16 2025-06-04 0.61
2025-05-04 2025-05-11 0.63
2025-04-30 2025-04-30 0.57
2025-04-24 2025-04-29 0.63
2025-04-16 2025-04-23 0.57
2025-03-18 2025-03-26 9.32
2025-02-18 2025-02-23 13.57

Vitro medis - VMI tax arrears

From To Overdue, €
2026-06-01 2026-06-02 10.43
2026-05-31 2026-05-31 5.52
2026-05-18 2026-05-18 634.12
2026-05-01 2026-05-03 4210.11
2026-04-30 2026-04-30 4206.84
2025-04-28 2025-04-30 1241.54

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Vitro medis, UAB (code 305115493) is a Private Limited Liability Company operating in other specialised wholesale n.e.c. In 2025, the company generated revenue of €358.8K, up 436.3% year on year and 462.8% over two years. Profitability improved sharply after the 2024 loss of €34.4K, although earnings remained minimal in 2025, with net profit of €237 and a profit margin of 0.1%. The prior trajectory shows revenue of €63.7K in 2023, €66.9K in 2024 and a substantial step-up in 2025, while profit moved from a €32.4K gain in 2023 to a loss in 2024 before returning close to break-even. The balance sheet remained stable, with total assets of €476.5K and equity of €424.9K at the end of 2025, supported by liabilities of €53.0K. The equity ratio was 89.2% and debt-to-equity 0.12, indicating a lightly leveraged structure. Asset turnover was 0.75x. With revenue per employee of €89.7K and profit per employee of €59, productivity increased in line with the higher turnover, but margins stayed very thin in the latest year.